Cargando…

Environmental Risk Characterization of an Antiretroviral (ARV) Lamivudine in Ecosystems

Antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) and other viral infections are among the emerging contaminants considered for ecological risk assessment. These compounds have been reported to be widely distributed in water bodies and other aquatic environments, while dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omotola, Elizabeth Oyinkansola, Genthe, Bettina, Ndlela, Luyanda, Olatunji, Olatunde Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391970/ https://www.ncbi.nlm.nih.gov/pubmed/34444108 http://dx.doi.org/10.3390/ijerph18168358

Ejemplares similares

Evaluation of the probable synergistic toxicity of selected potentiated antiretroviral and antibiotics on some aquatic biomarker organisms
por: Omotola, Elizabeth Oyinkansola, et al.
Publicado: (2023)

Quantification of selected pharmaceutical compounds in water using liquid chromatography-electrospray ionisation mass spectrometry (LC-ESI-MS)
por: Omotola, Elizabeth Oyinkansola, et al.
Publicado: (2020)

Removal of Antibiotics Using an Algae-Algae Consortium (Chlorella protothecoides and Chlorella vulgaris)
por: Ndlela, Luyanda L., et al.
Publicado: (2023)

Pharmaceuticals and personal care products in water and wastewater: a review of treatment processes and use of photocatalyst immobilized on functionalized carbon in AOP degradation
por: Oluwole, Adewumi Olufemi, et al.
Publicado: (2020)

Dolutegravir–lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study
por: Cahn, Pedro, et al.
Publicado: (2017)

Multi-residue method for the determination of selected veterinary pharmaceutical residues in surface water around Livestock Agricultural farms
por: Fatoki, Olalekan S., et al.
Publicado: (2018)

Evaluation of wild herbivore faeces from South Africa as a potential source of hydrolytically active microorganisms
por: Ndlela, Luyanda L., et al.
Publicado: (2016)

Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

Correction: Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)

COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages
por: Dada, David Adelekan, et al.
Publicado: (2020)

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
por: Manosuthi, Weerawat, et al.
Publicado: (2010)

Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
por: Satyanarayana, Kanikaram, et al.
Publicado: (2010)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
por: de Boissieu, Paul, et al.
Publicado: (2016)

Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
por: Kumar, Agibothu K Hemanth, et al.
Publicado: (2006)

Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
por: Castelli, Francesco, et al.
Publicado: (2010)

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study
por: Sapsirisavat, Vorapot, et al.
Publicado: (2016)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection
por: Deng, Lisi, et al.
Publicado: (2022)

Women and ARV-based prevention: opportunities and challenges
por: Geary, Cynthia W, et al.
Publicado: (2014)

Development of long-acting ARV’s
por: Boffito, Marta
Publicado: (2014)

Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999–2008
por: Buchacz, Kate, et al.
Publicado: (2012)

LB5. Safety of In Utero Antiretroviral (ARV) Exposure: Neurologic Outcomes in HIV-Exposed, Uninfected Children
por: Crowell, Claudia S, et al.
Publicado: (2018)

Women and ARV-based HIV prevention – challenges and opportunities
por: Geary, Cynthia W, et al.
Publicado: (2014)

Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya
por: Ng'ong'a, Gabriel O., et al.
Publicado: (2022)

Strategies to reduce risks in ARV supply chains in the developing world
por: Larson, Chris, et al.
Publicado: (2014)

ARV regimen choice and co-morbidities
por: Peters, Barry
Publicado: (2014)

Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025
por: Gupta, Aastha, et al.
Publicado: (2016)

550. Adherence and Persistency With Modern Single vs. Multi-Tablet Antiretroviral (ARV) Regimens in First Treatment of HIV in Clinical Practice
por: Mills, Anthony, et al.
Publicado: (2018)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020)

The ARV roll out and the disability grant: a South African dilemma?
por: de Paoli, Marina Manuela, et al.
Publicado: (2012)

Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings
por: Stalter, Randy M, et al.
Publicado: (2016)

Patent Pools for ARVs: Industry Perspectives from ASPEN
por: Nicolaou, Stavros
Publicado: (2010)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection
por: Boffito, Marta, et al.
Publicado: (2020)

Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
por: Naidoo, Pamela, et al.
Publicado: (2013)

Reducing Delays to Antiretroviral (ARV) Receipt in Children Prescribed Post-Exposure Prophylaxis (PEP) for HIV: Meds-in-Hand and a Multidisciplinary Team Approach
por: Epstein, Rachel, et al.
Publicado: (2017)

Quantification and Ecological Risk Assessment of Colloidal Fullerenes Nanoparticles in Sediments by Ultrasonic-Assisted Pressurized Liquid Extraction and High Performance Liquid Chromatography
por: Hendricks, Nokwanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdn9qq6oi2u9bh9ev3la0bi7a3